Ionis Pharmaceuticals, Inc. (IONS) /
The revenue of Ionis Pharmaceuticals, Inc. over the past 10 years
Chart Ionis Pharmaceuticals, Inc.: revenue, fiscal 2016–2025 Open the chart →Ionis Pharmaceuticals, Inc. reported revenue of $943.71M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $372.78M — up 153% over 9 years. Year over year, revenue rose 6 times and fell 3 times. In these years the highest was $1.12B in fiscal 2019. The largest one-year move was in fiscal 2019: up 87%, from $599.67M to $1.12B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $943.71M |
| 2024ended Dec 31, 2024 | $705.14M |
| 2023ended Dec 31, 2023 | $787.65M |
| 2022ended Dec 31, 2022 | $587.37M |
| 2021ended Dec 31, 2021 | $810.46M |
| 2020ended Dec 31, 2020 | $729.26M |
| 2019ended Dec 31, 2019 | $1.12B |
| 2018ended Dec 31, 2018 | $599.67M |
| 2017ended Dec 31, 2017 | $514.18M |
| 2016ended Dec 31, 2016 | $372.78M |
Fiscal years as Ionis Pharmaceuticals, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Ionis Pharmaceuticals, Inc.
- The profitability of Ionis Pharmaceuticals, Inc.
- The cash flow of Ionis Pharmaceuticals, Inc.
- The debt of Ionis Pharmaceuticals, Inc.
- All of Ionis Pharmaceuticals, Inc.'s financials, charted
Companies of a similar size
- EPAMEPAM SYSTEMS, INC.
- CVLTCommvault Systems, Inc
- CAGCONAGRA BRANDS, INC.
- MSAMSA SAFETY INC
- KEXKIRBY CORPORATION
Not investment advice. This page shows what Ionis Pharmaceuticals, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.